Position in GSK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$9,500,285
-$556,877 QoQ
Shares Held
181,234
-0.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#112
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bell Bank holds $61,862,123 across 10 Drug Manufacturers - General names. GSK ranks #5 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
53,948 | $13,575,473 | |
| 2 | AMGN |
Amgen Inc
|
33,672 | $12,193,303 | |
| 3 | PFE |
Pfizer Inc
|
484,403 | $11,664,423 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
78,616 | $9,932,345 | |
| 5 | GSK |
GSK plc
This page
|
181,234 | $9,500,285 | |
| 6 | LLY |
ELI LILLY & Co
|
2,255 | $2,704,714 | |
| 7 | JNJ |
Johnson & Johnson
|
5,046 | $1,281,532 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,672 | $471,852 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,500,285 | 181,234 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $10,057,162 | 182,228 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $9,033,167 | 184,200 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $8,324,743 | 192,881 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $7,171,813 | 186,766 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $7,557,476 | 195,082 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $6,138,769 | 181,513 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $6,169,241 | 150,911 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $6,760,176 | 175,589 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $7,534,831 | 175,760 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $6,498,989 | 175,364 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $6,292,057 | 173,574 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $6,255,497 | 175,519 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $6,655,594 | 187,060 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $5,647,138 | 160,704 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $5,358,202 | 182,066 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $7,744,049 | 181,384 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $7,207,607 | 168,703 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $6,167,009 | 142,579 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $4,402,648 | 117,478 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $4,251,225 | 108,851 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $3,416,253 | 97,594 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $3,128,723 | 86,684 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,336,570 | 63,292 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,630,089 | 65,741 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,283,196 | 88,347 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||